Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gastroenteritis
Data on gastroenteritis detailed by C.X. Fu and co-authors
March 12th, 2008
"We sought to determine the vaccine effectiveness (VE) of Lanzhou lamb rotavirus (LLR) vaccine against rotavirus gastroenteritis in children <5 requiring hospitalization. Children hospitalized 2002-2004 with rotavirus gastroenteritis were matched by gender, age and community to 838 controls," scientists in Guangzhou, People's Republic of China report. "VE was calculated for one or more doses of LLR vaccine with 95% confidence intervals (Q. For one dose versus zero doses, LLR vaccine VE was 73.3% (95% CI, range 61.2-81.6%). VE of one dose versus zero doses was higher in children 12-23 months than in children 2-11 months (80.9% versus 60.0%)," wrote C.X. Fu and...
Source: Vaccine Weekly (2008-03-12)
|
